Long-term efficacy and safety of prophylactic treatment with recombinant factor IX FC fusion protein (rFIXFc) in subjects with severe or moderate haemophilia B: final longitudinal analysis of B-LONG/kids B-LONG and B-YOND

被引：0
|
作者：
Shapiro, A. D. [1 ]
Kulkarni, R. [2 ]
Ragni, M. V. [3 ]
Mahlangu, J. [4 ,5 ]
Oldenburg, J. [6 ]
Nolan, B. [7 ]
Ozelo, M. C. [8 ]
Willemze, A. [9 ]
Feng, J. [10 ]
Barnowski, C. [10 ]
Barnes, C. [11 ]
机构：
[1] Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA
[2] Michigan State Univ, E Lansing, MI 48824 USA
[3] Univ Pittsburgh, Hemophilia Ctr Western Penn, Pittsburgh, PA USA
[4] Univ Witwatersrand, Haemophilia Comprehens Care Ctr, Fac Hlth Sci, Johannesburg, South Africa
[5] NHLS, Johannesburg, South Africa
[6] Univ Clin Bonn, Inst Expt Haematol & Transfus Med, Bonn, Germany
[7] Our Ladys Childrens Hosp, Dublin, Ireland
[8] Univ Estadual Campinas, Hemoctr UNICAMP, Sao Paulo, Brazil
[9] Sobi, Stockholm, Sweden
[10] Bioverativ, Waltham, MA USA
[11] Royal Childrens Hosp, Melbourne, Vic, Australia
来源：
HAEMOPHILIA | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P009
引用
收藏
页码：39 / 40
页数：2
相关论文
共 50 条
  • [21] Recombinant factor IX Fc fusion protein as episodic treatment for bleeding: Analysis from the B-LONG Study
    Pasi, John
    Ragni, Margaret
    Ozelo, Margaret
    Valentino, Leonard A.
    Jiang, Haiyan
    Dodd, Nigel
    Robinson, Brian
    Mei, Baisong
    Pierce, Glenn
    HAEMOPHILIA, 2014, 20 : 15 - 16
  • [22] Recombinant factor IXFc fusion protein in severe haemophilia B: association between fix activity and bleeding in B-LONG
    Hermans, C.
    Shapiro, A.
    Potts, J.
    Li, S.
    Valentino, L. A.
    Diao, L.
    Robinson, B.
    Pierce, G. F.
    Mei, B.
    Jiang, H.
    HAEMOPHILIA, 2014, 20 : 83 - 83
  • [23] Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 study
    Fischer, Kathelijn
    Kulkarni, Roshni
    Nolan, Beatrice
    Mahlangu, Johnny
    Rangarajan, Savita
    Gambino, Giulia
    Diao, Lei
    Ramirez-Santiago, Alejandra
    Pierce, Glenn F.
    Allen, Geoffrey
    LANCET HAEMATOLOGY, 2017, 4 (02): : E75 - E82
  • [24] Long-term efficacy and safety of prophylactic treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with severe haemophilia A: Final longitudinal analysis of A-LONG/kids A-LONG and ASPIRE
    Konkle, B.
    Young, G.
    Liesner, R.
    Mahlangu, J.
    Brown, S. A.
    Nolan, B.
    Tripkovic, N.
    Feng, J.
    Barnowski, C.
    HAEMOPHILIA, 2019, 25 : 55 - 55
  • [25] Effect of Sampling Duration on Pharmacokinetic (PK) Parameters of Recombinant Factor IX FC Fusion Protein (rFIXFc) in the Phase 3 B-LONG Study
    Berntorp, E.
    Mei, B.
    Lethagen, S.
    Li, S.
    HAEMOPHILIA, 2016, 22 : 44 - 44
  • [26] Clinical Outcomes in Adults/Adolescents with Hemophilia B Treated Long Term with Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis: Interim Results of the B-Yond Extension Study
    Matsushita, Tadashi
    Mahlangu, Johnny
    Shapiro, Amy D.
    Pasi, K. John
    Ragni, Margaret V.
    Ozelo, Margareth C.
    Oldenburg, Johannes
    Baker, Ross I.
    Yuan, Huixing
    Ramirez-Santiago, Alejandra
    Ferrante, Francesca
    Lethagen, Stefan
    BLOOD, 2016, 128 (22)
  • [27] Individualised Prophylaxis with Recombinant Factor IX FC Fusion Protein (RFIXFC) in Adults/Adolescents With Haemophilia B: Updated Interim Results of the B-YOND Extension Study
    Mahlangu, J. N.
    Shapiro, A. D.
    Pasi, K. J.
    Ragni, M. V.
    Ozelo, M. C.
    Oldenburg, J.
    Matsushita, T.
    Baker, R. I.
    Yuan, H.
    Ferrante, F.
    Ramirez-Santiago, A.
    Lethagen, S.
    Barnowski, C.
    HAEMOPHILIA, 2017, 23 : 85 - 86
  • [28] Final results of the PUPs B-LONG study: evaluating safety and efficacy of rFIXFc in previously untreated patients with hemophilia B
    Nolan, Beatrice
    Klukowska, Anna
    Shapiro, Amy
    Rauch, Antoine
    Recht, Michael
    Ragni, Margaret
    Curtin, Julie
    Gunawardena, Sriya
    Mukhopadhyay, Sutirtha
    Jayawardene, Deepthi
    Winding, Bent
    Fischer, Kathelijn
    Liesner, Raina
    BLOOD ADVANCES, 2021, 5 (13) : 2732 - 2739
  • [29] Extended-Interval Prophylaxis with Recombinant Factor IX FC Fusion Protein (rFIXFc) in Adults/Adolescents with Haemophilia B: Interim Results of the B-YOND Extension Study
    Mahlangu, J.
    Shapiro, A. D.
    Pasi, K. J.
    Ragni, M. V.
    Ozelo, M. C.
    Oldenburg, J.
    Matsushita, T.
    Baker, R. I.
    Yuan, H.
    Ramirez-Santiago, A.
    Pierce, G. F.
    Allen, G.
    Mei, B.
    HAEMOPHILIA, 2016, 22 : 46 - 47
  • [30] Population pharmacokinetic analysis of a long-acting recombinant factor IX-FC fusion protein (RFIXFC) in patients with severe haemophilia B
    Diao, L.
    Li, S.
    Nestorov, I.
    Jiang, H.
    HAEMOPHILIA, 2013, 19 : 33 - 33
12345